Human Genome Sciences Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 48.4 | 41.9 | 25.8 |
| Cost of Goods Sold | 0.0 | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 60.9 | 55.9 | 53.1 |
| Depreciation & Amortization | 21.4 | 22.1 | 20.1 |
| Operating Income | (205.4) | (223.1) | (224.2) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 49.7 | 0.0 | 14.8 |
| Nonoperating Expenses | (39.5) | -- | -- |
| Income Before Taxes | (244.9) | (262.4) | (251.2) |
| Income Taxes | 0.0 | 0.0 | 0.0 |
| Net Income After Taxes | (244.9) | (262.4) | (251.2) |
| Continuing Operations | (244.9) | (262.4) | (251.2) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (244.9) | (262.4) | (251.2) |
| Total Net Income | (244.9) | (262.4) | (251.2) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.81) | (1.95) | (1.91) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
